Schalken JA - Search Results

1

Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.

De Kok JB, Schalken JA, Aalders TW, Ruers TJ, Willems HL, Swinkels DW. De Kok JB, et al. Among authors: schalken ja. Int J Cancer. 2000 Jul 15;87(2):217-20. Int J Cancer. 2000. PMID: 10861477

2

Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.

Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA. Verhagen AP, et al. Among authors: schalken ja. Cancer Res. 1992 Nov 15;52(22):6182-7. Cancer Res. 1992. PMID: 1384957

3

Karyometry in recurrent superficial transitional cell tumors of the bladder.

van der Poel HG, van Caubergh RD, Boon ME, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: schalken ja. Urol Res. 1992;20(5):375-81. doi: 10.1007/BF00922753. Urol Res. 1992. PMID: 1455571

4

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Umbas R, et al. Among authors: schalken ja. Cancer Res. 1992 Sep 15;52(18):5104-9. Cancer Res. 1992. PMID: 1516067

5

HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.

Beniers AJ, Peelen WP, Debruyne FM, Schalken JA. Beniers AJ, et al. Among authors: schalken ja. Int J Cancer. 1991 Jul 9;48(5):709-16. doi: 10.1002/ijc.2910480514. Int J Cancer. 1991. PMID: 1906431

6

Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration.

Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA. Verhagen AP, et al. Among authors: schalken ja. Prostate. 1988;13(1):25-38. doi: 10.1002/pros.2990130104. Prostate. 1988. PMID: 2458583

7

Differential expression of the gene encoding the novel pituitary polypeptide 7B2 in human lung cancer cells.

Roebroek AJ, Martens GJ, Duits AJ, Schalken JA, van Bokhoven A, Wagenaar SS, Van de Ven WJ. Roebroek AJ, et al. Among authors: schalken ja. Cancer Res. 1989 Aug 1;49(15):4154-8. Cancer Res. 1989. PMID: 2545336

8

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. Among authors: schalken ja. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

9

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.

Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA. Umbas R, et al. Among authors: schalken ja. Cancer Res. 1994 Jul 15;54(14):3929-33. Cancer Res. 1994. PMID: 7518346

10

Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinoma.

van der Poel HG, Mulders PF, Aalders TW, Oosterhof GO, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: schalken ja. Anal Cell Pathol. 1994 Aug;7(2):153-70. Anal Cell Pathol. 1994. PMID: 7993825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters